Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 USD | -6.34% |
|
-3.13% | +71.67% |
10/06 | Pyxis Oncology, Inc. Appoints Michael A. Metzger to Its Board of Directors | CI |
14/05 | Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.67% | 19Cr | |
+15.94% | 12TCr | |
+19.54% | 11TCr | |
+17.47% | 2.6TCr | |
-25.15% | 1.94TCr | |
-19.51% | 1.59TCr | |
-18.81% | 1.51TCr | |
-46.87% | 1.51TCr | |
+63.31% | 1.49TCr | |
+5.36% | 1.39TCr |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.
- Leerink Partners Initiates Coverage on Pyxis Oncology with Outperform Rating, $12 Price Target